Skip to main content
Caplight Logo









Sperax

Sperax

Private
Menlo Park, CaliforniaCrypto & Web3https://www.sperax.io/

Last Round

Private Placement

Dec 29, 2021

Est. Valuation

$200M

Total Funding Raised

$10.8M

Company Overview

Sperax is a blockchain technology company that develops decentralized finance (DeFi) infrastructure, including the auto-yielding stablecoin USDs and the SperaxOS financial automation platform.

Sector

Crypto & Web3

Verticals

DeFi, Stablecoins, Blockchain Infrastructure, DAOs, Staking Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS, Marketplace Commission, Revenue Share

AI Layer

Infrastructure

Keywords

decentralized stablecoinyield-bearing stablecoinDeFi protocolautonomous DeFi agentsAI agent workspaceliquidity managementblockchain infrastructureModel Context ProtocolMCPgovernance tokenyield farmingon-chain automationAI agent securityvibe codingDeFi yield aggregator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sperax Comparables

Compare Sperax with similar companies based on industry and business-model similarity.

Sperax comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Frax Finance
82%
Origin Protocol
82%
Angle
82%

Sperax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementDec 29, 2021
StrategicAug 20, 2020
SeedJan 1, 2020

Sperax Investors

Notable investors and investment history

Sperax investors
InvestorRounds
FBG CapitalSeed
Alameda ResearchPrivate Placement
New Capital PartnersSeed
Outlier VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    Monthly visitors grew 56% MoM.

  • Sep 23, 2024

    Grew 24% QoQ, from 25 to 31 employees.

Sperax Filings

Explore SEC and related filing metadata, where available.

Sperax filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sperax's valuation, stock price, and market status.

Is Sperax a public or private company?

Sperax is a private company.

What is the current stock price of Sperax?

Sperax is a private company, so its shares have no public market price. Caplight tracks Sperax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sperax worth (valuation)?

Sperax's valuation is estimated at $200.0M based on funding round data.

Can I buy Sperax stock?

Sperax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sperax's last funding round?

Sperax's most recent funding round was Private Placement on December 29, 2021.

Who are the main investors in Sperax?

Key investors in Sperax include FBG Capital, Alameda Research, New Capital Partners, Outlier Ventures.

Will Sperax IPO soon?

No public IPO plans have been announced for Sperax.

How can I track Sperax secondary market activity?

Caplight tracks bids, offers, and trades in Sperax's shares on secondary markets.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range21
Year Founded2019
Last FundingDec 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?